MCGI focuses on personalized cancer therapy. By testing the genomic profile of your individual cancer it is possible to identify the treatment most likely to work for you. The MCGI team is working with all oncology practices in Maine to ensure that people diagnosed with cancer in the state have access to genomic tumor testing, innovative clinical trials and individualized therapies.
Explore patient focused resources developed by MCGI below. Each page offers tools to help patients and caregivers learn more about cancer, the care journey and the support available.
Collaboration is central to MCGI, which extends cancer genomic testing, education, and drug access infrastructure across Maine and beyond.
A collection of latest news and publications focusing on Maine Cancer Genomics Initiative (MCGI).
Find local and online support groups, lodging, travel, and financial support resources.
Explore different MCGI educational resources and materials for cancer patients.
Learn moreJoin the MCGI PAC to help improve cancer patients' experiences and understanding of available resources.
Maine cancer patients experienced better outcomes following genomic tumor testing to guide targeted therapy strategies; but a gap between testing and clinical delivery still exists.
View more
In a paper published in JCO Precision Oncology, the Maine Cancer Genomics Initiative (MCGI) team, led by Professor and former JAX President and CEO Ed Liu, M.D., and Chief Medical Officer Jens Rueter, M.D., presents the highly successful launch and implementation of the first phase of MCGI.
View more